| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the New York State Institute for Basic Research in Developmental Disabilities (Drs. Wisniewski and Zhong), Staten Island; State University of New York/Health Science Center of Brooklyn (Drs. Wisniewski and Zhong), NY; and Brain Research Institute (Dr. Philippart), University of California, Los Angeles.
Address correspondence and reprint requests to Dr. K.E. Wisniewski, NYS Institute for Basic Research in Developmental Disabilities, 1050 Forest Hill Road, Staten Island, NY 10314; e-mail: battenkw{at}aol.com
The neuronal ceroid lipofuscinoses (NCL) are a large group of autosomal recessive lysosomal storage disorders with both enzymatic deficiency and structural protein dysfunction. Previously, diagnosis of NCL was based on age at onset and clinicopathologic (C-P) findings, classified as 1) infantile (INCL), 2) late infantile (LINCL), 3) juvenile (JNCL), and 4) adult (ANCL). Most patients with NCL have progressive ocular and cerebral dysfunction, including cognitive/motor dysfunction and uncontrolled seizures. After reviewing 319 patients with NCL, the authors found that 64 (20%) did not fit into this classification of NCL. With research progress, four additional forms have been recognized: 5) Finnish, 6) Gypsy/Indian, and 7) Turkish variants of LINCL and 8) northern epilepsy, also known as progressive epilepsy with mental retardation. These eight NCL forms resulted from 100 different mutations on genes CLN1to CLN8 causing different phenotypes (http://www.ucl.ac.uk/ncl). The genes CLN1 and CLN2 encode lysosomal palmitoyl protein thioesterase and tripeptidyl peptidase 1. The function of CLN3, CLN5, and CLN8 gene-encoded products is unknown, although their predicted amino acid sequences suggest they have a transmembrane topology. The diagnosis of NCL is based on C-P findings, enzymatic assay, and molecular genetic testing. Before biochemical and genetic tests are conducted, ultrastructural studies (i.e., blood [buffy coat] or punch biopsies [skin, conjunctiva]) must be performed to confirm the presence and nature of lysosomal storage material (fingerprint or curvilinear profiles or granular osmiophilic deposits). The recognition of variable onset from infancy to middle age supersedes the traditional emphasis on age-related NCL forms.
This article has been cited by other articles:
|
|
 |
|
  A. Zini, G. Cenacchi, P. Nichelli, E. Zunarelli, A. Todeschini, and S. Meletti Early-onset dementia with prolonged occipital seizures: An atypical case of Kufs disease Neurology, November 18, 2008; 71(21): 1709 - 1712. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Koul, A. Al-Futaisi, A. Ganesh, and S. Rangnath Bushnarmuth Late-Infantile Neuronal Ceroid Lipofuscinosis (CLN2/Jansky-Bielschowsky Type) in Oman J Child Neurol, May 1, 2007; 22(5): 555 - 559. [Abstract] [PDF]
|
|
|
|
 |
|
 Y. Cao, J. A. Espinola, E. Fossale, A. C. Massey, A. M. Cuervo, M. E. MacDonald, and S. L. Cotman Autophagy Is Disrupted in a Knock-in Mouse Model of Juvenile Neuronal Ceroid Lipofuscinosis J. Biol. Chem., July 21, 2006; 281(29): 20483 - 20493. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-J. Kim, Z. Zhang, E. Hitomi, Y.-C. Lee, and A. B. Mukherjee Endoplasmic reticulum stress-induced caspase-4 activation mediates apoptosis and neurodegeneration in INCL Hum. Mol. Genet., June 1, 2006; 15(11): 1826 - 1834. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-J. Kim, Z. Zhang, Y.-C. Lee, and A. B. Mukherjee Palmitoyl-protein thioesterase-1 deficiency leads to the activation of caspase-9 and contributes to rapid neurodegeneration in INCL Hum. Mol. Genet., May 15, 2006; 15(10): 1580 - 1586. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Zhang, Y.-C. Lee, S.-J. Kim, M. S. Choi, P.-C. Tsai, Y. Xu, Y.-J. Xiao, P. Zhang, A. Heffer, and A. B. Mukherjee Palmitoyl-protein thioesterase-1 deficiency mediates the activation of the unfolded protein response and neuronal apoptosis in INCL Hum. Mol. Genet., January 15, 2006; 15(2): 337 - 346. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R. Pears, J. D. Cooper, H. M. Mitchison, R. J. Mortishire-Smith, D. A. Pearce, and J. L. Griffin High Resolution 1H NMR-based Metabolomics Indicates a Neurotransmitter Cycling Deficit in Cerebral Tissue from a Mouse Model of Batten Disease J. Biol. Chem., December 30, 2005; 280(52): 42508 - 42514. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. K. Cho, N. Gao, D. A. Pearce, M. A. Lehrman, and S. L. Hofmann Characterization of lipid-linked oligosaccharide accumulation in mouse models of Batten disease Glycobiology, June 1, 2005; 15(6): 637 - 648. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. K. Inlow and L. L. Restifo Molecular and Comparative Genetics of Mental Retardation Genetics, February 1, 2004; 166(2): 835 - 881. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. de los Reyes, P. R. Dyken, P. Phillips, M. Brodsky, S. Bates, C. Glasier, and R. E. Mrak Profound Infantile Neuroretinal Dysfunction in a Heterozygote for the CLN3 Genetic Defect J Child Neurol, January 1, 2004; 19(1): 42 - 46. [Abstract] [PDF]
|
|
|
|
 |
|
 A Reif, M F Schneider, A Hoyer, C Schneider-Gold, A J Fallgatter, W Roggendorf, and B Pfuhlmann Neuroleptic malignant syndrome in Kufs' disease J. Neurol. Neurosurg. Psychiatry, March 1, 2003; 74(3): 385 - 387. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Conry Progressive Myoclonic Epilepsies J Child Neurol, January 1, 2002; 17(1_suppl): S80 - S84. [Abstract] [PDF]
|
|
|
|
 |
|
 Classification of the Neuronal Ceroid Lipofuscinoses Journal Watch Neurology, November 9, 2001; 2001(1109): 4 - 4. [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
